Does One Size Fit All?
By Jay S. Kaufman,
Los Angeles Review of Books
| 09. 27. 2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in collaboration with the Los Angeles Review of Books, and supported by the Center for Genetics and Society, the Othering & Belonging Institute, and Berkeley Public Health.
HOW LARGE SHOULD members of our species be? Even before birth, many of us are assessed through ultrasounds to determine if we are the “right” size. The women who gestate us are weighed throughout pregnancy to determine if they are gaining the “right” amount of weight. Once we are born, growth charts track our progress toward full stature. Thereafter, our girth may be scrutinized relentlessly, with the balance scale being the clinical device we encounter—and likely resent—more than any other.
The eugenics movement was premised on the notion of amplifying favorable traits in the population, but this requires knowing which value of a trait is optimal. To this end, the early eugenicists became...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...